Articles published by Syros Pharmaceuticals, Inc.
Syros Announces Closing of Merger with Tyme Technologies and Concurrent Private Placement
September 16, 2022
Via Business Wire
Tickers
SYRS
Syros and Tyme Technologies Announce Stockholder Approval of Merger
September 15, 2022
Via Business Wire
Syros Receives FDA Orphan Drug Designation for SY-5609 for the Treatment of Pancreatic Cancer
September 13, 2022
Via Business Wire
Tickers
SYRS
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Kelownadailycourier.ca
Phone number: (250) 763-4000
E-mail: csr@ok.bc.ca
Address: 550 Doyle Avenue
Kelowna, BC V1Y 7V1
© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.